CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Recently, a study showed that combining Imatinib with Ovatodiolide, a natural diterpenoid that up-regulates miR-155 to inhibit PI3K/mTOR, efficiently induced cell death of CD34+/CD38− CML cells.